Shattuck Labs (STTK) Free Cash Flow (2019 - 2026)
Shattuck Labs (STTK) reported Free Cash Flow of -$13.5 million for Q1 2026, down 12.09% year-over-year from -$15.3 million in Q1 2025, and down 58.86% quarter-over-quarter from -$8.5 million in Q4 2025.
Shattuck Labs (STTK) Free Cash Flow (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Free Cash Flow data on file, last reported at -$13.5 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$13.5 million, down 12.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$41.4 million (up 26.64% YoY), and the FY2025 annual result was -$40.0 million, up 34.04% from the prior year.
- Free Cash Flow fell to -$13.5 million in Q1 2026 per STTK's latest filing, from -$8.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$8.5 million in Q4 2025 and troughed at -$38.8 million in Q3 2022.
- A 5-year average of -$17.8 million and a median of -$16.2 million in 2024 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 159.89% in 2022, then surged 55.91% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$24.5 million in 2022, then gained by 20.78% to -$19.4 million in 2023, then rose by 10.63% to -$17.4 million in 2024, then jumped by 51.12% to -$8.5 million in 2025, then slumped by 58.86% to -$13.5 million in 2026.
- Business Quant data shows STTK's Free Cash Flow at -$13.5 million in Q1 2026, -$8.5 million in Q4 2025, and -$9.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | -13.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.49 Mn |
| Mar 31, 2026 | -13.49 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Sep 30, 2024 | -16.12 Mn |
| Sep 30, 2024 | -16.12 Mn |
| Jun 30, 2024 | -10.93 Mn |
| Jun 30, 2024 | -10.93 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Dec 31, 2023 | -19.44 Mn |
| Dec 31, 2023 | -19.44 Mn |